Shape Our Content: Take The Reader Survey bit.ly/4ebF0zW #PinkSheet

EU-US-Japanese-Indian Pharmacopeia Group Says ‘New Members Wanted’ pink.citeline.com/articles/2024/…

Henlius Reports Near 10% Revenue Growth In First Half Of 2024 generics.citeline.com/articles/2024/…

Lupin Marks Its Second Canadian Biosimilar Approval With Pegfilgrastim generics.citeline.com/articles/2024/…

Shape Our Content: Take The Reader Survey scrip.citeline.com/articles/2024/…

Cluster Wars: Korea’s Challenges In Shaping a Boston Style Biopharma Hub pink.citeline.com/articles/2024/…

Have you tried the all-new Citeline News and Insights app? Access all your favorite award-winning publications, all in one place. Download the app today: ow.ly/OUfz50SAk1K. (Available on the App Store and Google Play.)

FREE ACCESS roundup of notable quotes from execs and officials as compiled by Scrip, Citeline Commercial's on-the-ground APAC team #pharma #biotech Quotable: Words Of Wisdom From Our Recent APAC Coverage scrip.citeline.com/articles/2024/…

Chinese Cell And Gene Therapies Enjoy Limelight Amid Summer Fundraising Lull scrip.citeline.com/articles/2024/…

Pink Sheet Podcast: Rare Pediatric Disease PRV Deadline, Potential Makena Compounding Ban bit.ly/3ARAnMZ #PinkSheet

US Lawmakers Consider Crackdown on Clinical Trials In China, Here Are the Impacts bit.ly/4ggYRzp #PinkSheet

Glenmark Shells Out Another $25m To Resolve Civil Price-Fixing Charges bit.ly/3MCUOjw #PinkSheet

Huge result for Akeso/Summit in lung cancer at #WCLC24 scrip.citeline.com/SC150866/Akeso…

.Vibha Ravi talks to former Hilleman CEO Davinder Gill for Scrip, Citeline Commercial #pharma #vaccines scrip.citeline.com/SC150857/Forme…

🌟 News. Context. Impact: your weekly premium content roundup. Click below to read individual articles. Check back next week for more! Scrip—ow.ly/hZtr50TfHAu. Pink Sheet—ow.ly/AMLt50TfHAt. In Vivo—ow.ly/ntQY50TfHAw. Medtech Insight—ow.ly/3IHk50TfHAq.

Merck & Co and Daiichi’s Phase II ADC Hit Raises Expectations. Ifinatamab deruxtecan, a potential first-in-class B7-H3-targeted conjugate, looks promising – but the real test is to come.      Related StoriesAstraZeneca's Hopes Still... ow.ly/H0AP105I85L #PharmaScrip

Join Jung Won Shin in her latest Korean-language mini #podcast, this episode on J&J's plans in #obesity. On your usual platforms incl. Spotify below: open.spotify.com/episode/6ajZ3g…

Glenmark Shells Out Another $25m To Resolve Civil Price-Fixing Charges pink.citeline.com/articles/2024/…

Join Lisa Takagi in her latest Japanese-language mini #podcast, this time looking at Chinese #pharma firms' rising clinical trials in Japan. On your usual platforms incl. @spotify below. open.spotify.com/episode/7KKah4…